{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:20:46Z","timestamp":1793164846866,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Ministry of Education, Science, and Culture of Japan","award":["Grant-in-Aid for Scientific Research (17K08732)"],"award-info":[{"award-number":["Grant-in-Aid for Scientific Research (17K08732)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Other iatrogenic immunodeficiency-associated (OIIA) T- and natural killer (NK)-cell lymphoproliferative disorders (TNK-LPDs) are rare in patients with rheumatoid arthritis (RA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We investigated the clinicopathological characteristics, Epstein\u2013Barr virus (EBV) infection, genetic findings, therapeutic response, and prognostic factors in 21 RA patients with OIIA TNK-LPDs and compared these with those of 39 with OIIA B-cell LPDs (B-LPDs) and 22 with non-OIIA B-LPDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Immunohistologically, 11 patients (52%) showed CD4+ T-LPDs, and 7 had a T follicular helper (TFH) phenotype. The other nine patients (43%) showed CD8+ T-LPDs, and the remaining one (5%) had features of CD3+ CD4\u2212 CD8\u2212 nasal type TNK-cell lymphoma. CD30+, p53+, and CMYC+ atypical lymphocytes were identified in seven (33%), eight (38%), and five (24%) patients, respectively. In situ hybridisation detected EBV-encoded RNA (EBER)\u2009+\u2009large atypical lymphocytes in five patients (24%). Nine of 17 patients (53%) showed clonal peaks of <jats:italic>TCR\u03b3<\/jats:italic> by polymerase chain reaction. Withdrawal of MTX and biologic drugs was effective in 12 patients (57%), and 8 (38%) received chemotherapies. Two patients with TFH+ or EBV+ CD4+ CD30+ large cell peripheral T-cell lymphoma, one with CD8+ systemic anaplastic large cell lymphoma, and two with systemic EBV+ CD8+ T-cell lymphoma of childhood showed a lethal progressive clinical course within 13\u2009months. Moreover, &gt;\u2009500\u2009U\/L LDH, large atypical lymphocytes, expression of CD30, p53, and CMYC, and EBER+ atypical lymphocytes were significantly poor prognostic factors for overall survival (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Median interval from RA onset to OIIA TNK-LPDs was 72\u2009months, which was shorter than 166\u2009months in OIIA B-LPDs (<jats:italic>p<\/jats:italic>\u2009=\u20090.003). EBV+ atypical and reactive lymphocytes were frequently found in 15 patients with OIIA TNK-LPDs (71%), in 27 with OIIA B-LPDs (69%), and only in 3 with non-OIIA B-LPDs (14%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>OIIA TNK-LPDs occurred in early phase of RA, compared with OIIA B-LPDs, and occasionally showed a lethal progressive clinical course. Detection of OIIA TNK-LPD patients with poor prognostic factors is necessary. EBV infection in immunosuppressed patients due to persistent RA, MTX, and biologic drugs may play a role in forming the tumour microenvironment and lymphomagenesis of TNK-LPDs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10358-0","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T04:21:20Z","timestamp":1671682880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinicopathological findings, prognosis, and Epstein\u2013Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders"],"prefix":"10.1186","volume":"22","author":[{"given":"Shoichi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Daa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-2081","authenticated-orcid":false,"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"10358_CR1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised","year":"2017","unstructured":"Swerdlow S, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, revised. 4th ed. Lyon: IARC Press; 2017.","edition":"4"},{"issue":"11","key":"10358_CR2","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.v99.113909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. and the investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: A 3-year prospective study in France. Blood. 2002;99(11):3909\u201315. https:\/\/doi.org\/10.1182\/blood.v99.113909.","journal-title":"Blood."},{"issue":"1","key":"10358_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/his.12627","volume":"67","author":"K Yamada","year":"2015","unstructured":"Yamada K, Oshiro Y, Okamura S, Fujisaki T, Kondo S, Nakayama Y, et al. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Histopathol. 2015;67(1):70\u201380. https:\/\/doi.org\/10.1111\/his.12627.","journal-title":"Histopathol."},{"issue":"7","key":"10358_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","volume":"43","author":"D Kurita","year":"2019","unstructured":"Kurita D, Miyoshi H, Ichikawa A, Kato K, Imaizumi Y, Seki R, et al. Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis clinicopathologic features and prognostic factors. Am J Surg Pathol. 2019;43(7):869\u201384. https:\/\/doi.org\/10.1097\/PAS.0000000000001271.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10358_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s10165-010-0300-z","volume":"20","author":"S Hatachi","year":"2010","unstructured":"Hatachi S, Kunitomi A, Aozasa K, Yagita M. CD8+ T-cell lymphoproliferative disorder associated with Epstein\u2212Barr virus in a patient with rheumatoid arthritis during methotrexate therapy. Mod Rheumatol. 2010;20(5):500\u20135. https:\/\/doi.org\/10.1007\/s10165-010-0300-z.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10358_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.prp.2009.03.005","volume":"206","author":"K Hatanaka","year":"2010","unstructured":"Hatanaka K, Nakamura N, Kojima M, Ando K, Irie S, Bunnno M, et al. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma. Pathol Res Pract. 2010;206(1):9\u201313. https:\/\/doi.org\/10.1016\/j.prp.2009.03.005.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10358_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00428-013-1389-1","volume":"462","author":"S Kondo","year":"2013","unstructured":"Kondo S, Tanimoto K, Yamada K, Yoshimoto G, Suematsu E, Fujisaki T, et al. Mature T\/NK-cell lymphoproliferative disease and Epstein\u2212Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch. 2013;462(4):399\u2013407. https:\/\/doi.org\/10.1007\/s00428-013-1389-1.","journal-title":"Virchows Arch"},{"issue":"8","key":"10358_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41379-019-0264-2","volume":"32","author":"A Satou","year":"2019","unstructured":"Satou A, Tabata T, Miyoshi H, Kohno K, Suzuki Y, Yamashita D, et al. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype; clinicopathological analysis of 28 cases. Mod Pathol. 2019;32(8):1135\u201346. https:\/\/doi.org\/10.1038\/s41379-019-0264-2.","journal-title":"Mod Pathol"},{"issue":"2","key":"10358_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3960\/jslrt.19013","volume":"59","author":"A Satou","year":"2019","unstructured":"Satou A, Tsuzuki T, Nakamura S. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders with a T- or NK-cell phenotype. J Clin Exp Hematopathol. 2019;59(2):56\u201363. https:\/\/doi.org\/10.3960\/jslrt.19013.","journal-title":"J Clin Exp Hematopathol"},{"issue":"12","key":"10358_CR10","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/art.40654","volume":"70","author":"EC Schwaneck","year":"2018","unstructured":"Schwaneck EC, Renner R, Junker L, Einsele H, Gadeholt O, Geissinger E, et al. Prevalence and characteristics of persistent clonal T cell large granular lymphocyte expansions in rheumatoid arthritis. A comprehensive analysis of 529 Patients. Arth. Rheumatol. 2018;70(12):1914\u201322. https:\/\/doi.org\/10.1002\/art.40654.","journal-title":"Rheumatol."},{"issue":"4","key":"10358_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00296-009-1184-0","volume":"31","author":"C Bes","year":"2011","unstructured":"Bes C, Bes ZS, Vard\u0131 S, Soy M. Anaplastic large cell lymphoma in a patient with rheumatoid arthritis. Rheumatol Int. 2011;31(4):533\u20135. https:\/\/doi.org\/10.1007\/s00296-009-1184-0.","journal-title":"Rheumatol Int"},{"issue":"1","key":"10358_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/PAS.0000000000001174","volume":"43","author":"AA Gru","year":"2019","unstructured":"Gru AA, Williams E, Junkins-Hopkins JM. An immune suppression-associated EBV-positive anaplastic large cell lymphoma with a BRAF V600E mutation. Am J Surg Pathol. 2019;43(1):140\u20136. https:\/\/doi.org\/10.1097\/PAS.0000000000001174.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10358_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","volume":"23","author":"D Parakkal","year":"2011","unstructured":"Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED. Hepatosplenic T-cell lymphoma in patients receiving TNF-\u03b1 inhibitor therapy: Expanding the groups at risk. Eur J Gastroenterol Hepatol. 2011;23(12):1150\u20136. https:\/\/doi.org\/10.1097\/MEG.0b013e32834bb90a.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10358_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","volume":"26","author":"R Rizzi","year":"2009","unstructured":"Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, et al. Spontaneous remission of \u201cmethotrexate-associated lymphoproliferative disorders\u201d after discontinuation of immunosuppressive treatment for autoimmune disease. Med Oncol. 2009;26(1):1\u20139. https:\/\/doi.org\/10.1007\/s12032-008-9069-8.","journal-title":"Med Oncol"},{"issue":"4","key":"10358_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5858\/arpa.2020-0802-RA","volume":"146","author":"SP Tanya","year":"2022","unstructured":"Tanya SP, Cullen ML, Kamran MM. Hemophagocytic lymphohistiocytosis. Arch Pathol Lab Med. 2022;146(4):507\u201319. https:\/\/doi.org\/10.5858\/arpa.2020-0802-RA.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10358_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","volume":"43","author":"BM Basha","year":"2019","unstructured":"Basha BM, Bryant SC, Rech KL, Feldman AL, Vrana JA, Shi M, et al. Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype. Am J Surg Pathol. 2019;43(9):1282\u201390 https:\/\/doi.org\/10.1097\/PAS.0000000000001315.","journal-title":"Am J Surg Pathol"},{"key":"10358_CR17","doi-asserted-by":"publisher","unstructured":"Wang Z, Kimura S, Iwasaki H, Takase K, Oshiro Y, Gamachi A, et al. Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults. Diag Pathol. 2021;16(1):48. https:\/\/doi.org\/10.1186\/s13000-021-01107-1.","DOI":"10.1186\/s13000-021-01107-1"},{"issue":"12","key":"10358_CR18","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardisation of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Leukemia. 2003;17(12):2257\u2013317. https:\/\/doi.org\/10.1038\/sj.leu.2403202.","journal-title":"Leukemia."},{"issue":"8","key":"10358_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/PAS.0000000000000651","volume":"40","author":"R Nagao","year":"2016","unstructured":"Nagao R, Kikuchi YY, Carreras J, Kikuchi T, Miyaoka M, Matsushita H, et al. Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with or without RHOA G17V mutation using formalin-fixed paraffin-embedded sections. Am J Surg Pathol. 2016;40(8):1041\u201350. https:\/\/doi.org\/10.1097\/PAS.0000000000000651.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10358_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2020.06.003","volume":"125","author":"G Cao","year":"2020","unstructured":"Cao G, Wang P, Cui Z, Yue X, Chi S, Ma A, et al. An imbalance between blood CD4+ CXCR5+ Foxp3+ Tfr cells and CD4+ CXCR5+ Tfh cells may contribute to the immunopathogenesis of rheumatoid arthritis. Mol Immunol. 2020;125(9):1\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2020.06.003.","journal-title":"Mol Immunol"},{"issue":"2","key":"10358_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4049\/jimmunol.181.2.991","volume":"181","author":"JD Lunemann","year":"2008","unstructured":"Lunemann JD, Frey O, Eidner T, Bajer M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol. 2008;181(2):991\u20131000. https:\/\/doi.org\/10.4049\/jimmunol.181.2.991.","journal-title":"J Immunol"},{"issue":"8","key":"10358_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00296-005-0051-x","volume":"26","author":"SK Kim","year":"2006","unstructured":"Kim SK, Kim IS, Jun JB. Anaplastic large cell lymphoma in a patient with rheumatoid arthritis taking low dose methotrexate. Rheumatol Int. 2006;26(8):775\u20136. https:\/\/doi.org\/10.1007\/s00296-005-0051-x.","journal-title":"Rheumatol Int"},{"issue":"1","key":"10358_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8097965","volume":"11","author":"XA Andrade","year":"2018","unstructured":"Andrade XA, Fuentes HE, Oramas DM, Mann H, Kovarik P. Iatrogenic T-cell lymphoma with associated hemophagocytic lymphohistiocytosis in a patient with long-standing rheumatoid arthritis. Case Rep Hematol. 2018;11(1):1\u20134. https:\/\/doi.org\/10.1155\/2018\/8097965.","journal-title":"Case Rep Hematol"},{"issue":"11","key":"10358_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/cup.13331","volume":"45","author":"T Rogers","year":"2018","unstructured":"Rogers T, McGevna L, Cook DL. Pediatric cutaneous T-cell post-transplant lymphoproliferative disorder. J Cut Pathol. 2018;45(11):858\u201363. https:\/\/doi.org\/10.1111\/cup.13331.","journal-title":"J Cut Pathol"},{"issue":"3","key":"10358_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/pbc.20231","volume":"44","author":"TI George","year":"2005","unstructured":"George TI, Jeng M, Berquist W, Cherry AM, Link MP, Arber DA. Epstein\u2013Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation. Pediatr Blood Cancer. 2005;44(3):270\u20136. https:\/\/doi.org\/10.1002\/pbc.20231.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10358_CR26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.leukres.2005.10.022","volume":"30","author":"N Awaya","year":"2006","unstructured":"Awaya N, Adachi A, Mori T, Kamata H, Nakahara J, Yokoyama K, et al. Fulminant Epstein\u2212Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma. Leukemia Res. 2006;30(8):1059\u201362. https:\/\/doi.org\/10.1016\/j.leukres.2005.10.022.","journal-title":"Leukemia Res"},{"issue":"1","key":"10358_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ejh.12116","volume":"91","author":"A Ichikawa","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Nino D, et al. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: Histology, Epstein\u2212Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91(1):20\u20138. https:\/\/doi.org\/10.1111\/ejh.12116.","journal-title":"Eur J Haematol"},{"issue":"10","key":"10358_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.humpath.2018.05.026","volume":"80","author":"H-S Huang","year":"2018","unstructured":"Huang H-S, Liao C-K, Liu T-T, You H-L, Wang M-C, Huang WT. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018;80(10):145\u201351. https:\/\/doi.org\/10.1016\/j.humpath.2018.05.026.","journal-title":"Hum Pathol"},{"issue":"8","key":"10358_CR29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/PAS.0000000000000871","volume":"41","author":"Y Mihashi","year":"2017","unstructured":"Mihashi Y, Mizoguchi M, Takamatsu Y, Ishitsuka K, Iwasaki H, Koga M, et al. C-MYC and its main ubiquitin ligase, FBXW7, influence cell proliferation and prognosis in adult T-cell leukemia\/lymphoma. Am J Surg Pathol. 2017;41(8):1139\u201349. https:\/\/doi.org\/10.1097\/PAS.0000000000000871.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10358_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/\/s00428-016-2030-x","volume":"470","author":"K Ejima-Yamada","year":"2017","unstructured":"Ejima-Yamada K, Oshiro Y, Okumura FT, Kondo S, Nakayama Y, Suematsu E, et al. Epstein\u2212Barr virus infection and gene promoter hypermethylation in in rheumatoid arthritis patients with methotrexate-associated B-cell lymphoproliferative disorders. Virchows Arch. 2017;470(2):205\u201315. https:\/\/doi.org\/10.1007\/\/s00428-016-2030-x.","journal-title":"Virchows Arch"},{"issue":"7","key":"10358_CR31","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.55563\/clinexprheumatol\/lgfbtq","volume":"40","author":"N Kitamura","year":"2022","unstructured":"Kitamura N, Sugiyama K, Nagasawa Y, Hamaguchi M, Kobayashi H, Takei M. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2022;40(7):1330\u20135. https:\/\/doi.org\/10.55563\/clinexprheumatol\/lgfbtq.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10358_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cancers13040610","volume":"13","author":"N Bayda","year":"2021","unstructured":"Bayda N, Tilloy V, Chaunavel A, Bahri R, Halabi MA, Feuillard J, et al. Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas. Cancers. 2021;13(4):610. https:\/\/doi.org\/10.3390\/cancers13040610.","journal-title":"Cancers."},{"issue":"3","key":"10358_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","volume":"4","author":"Y Okuno","year":"2019","unstructured":"Okuno Y, Murata Y, Sato Y, Muramatsu H, Ito Y, Watanabe T, et al. Defective Epstein\u2013Barr virus in chronic active infection and haematological malignancy. Nat Microbiol. 2019;4(3):404\u201313. https:\/\/doi.org\/10.1038\/s41564-018-0334-0.","journal-title":"Nat Microbiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10358-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T04:21:35Z","timestamp":1671682895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10358-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10358"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10358-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the ethics committee of the Faculty of Medicine Fukuoka University (U-20-05-002). The research title was \u2018Analysis of EBV+ T\/NK cell lymphoma\u2019, which was accepted on May 20th, 2020. Due to the retrospective and non-invasive study designs, the ethical review board approved a waiver of written consent to use the specimens of lymphoproliferative disorders.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no significant relationships with, or financial interests in, any commercial activities pertaining to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1342"}}